Neustadt an der Weinstraße, Germany

Stephan Urban

This inventor holds 13 USPTO granted patents and 3 published patent applications and 9 EPO patents, primarily in Liver Disease Treatments. Top assignees: Ruprecht-Karls-Universitat Heidelberg, National Institute of Health and Medical Research, Universitat Heidelberg. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Urban. Retrieved from https://idiyas.com/inventor/stephan-urban

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 69.2

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Neustadt-Allemagne, DE (2011)
  • Neustadt-Weinstrasse, DE (2019)
  • Neustadt/Weinstrasse, DE (2019 - 2022)
  • Neustadt, DE (2017 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Lipopeptides
Hepatitis B Virus
Cardiovascular Diseases
Hydrophobic Peptides
HDV Infections
Liver Targeting
Drug Delivery
Synthetic Polypeptides
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephan Urban

Introduction

Stephan Urban is a prominent inventor based in Neustadt/Weinstrasse, Germany. He has made significant contributions to the field of medical science, particularly in the development of treatments for liver and cardiovascular diseases. With a total of 13 patents to his name, Urban's work is characterized by its innovative approach to addressing critical health issues.

Latest Patents

Among his latest patents, Urban has developed lipopeptides for use in treating liver diseases and cardiovascular diseases. This invention relates to lipopeptide-based compounds that can be utilized in the diagnosis, prevention, and treatment of liver conditions, particularly metabolic diseases. Additionally, these compounds play a role in controlling cholesterol levels, thereby aiding in the management of cardiovascular diseases. Urban's patent also includes methods for testing the NTCP-mediated transport of these compounds, providing a comprehensive approach to treatment. Another notable patent focuses on the rapid detection of hepatitis D virus (HDV) infections. This invention encompasses a polypeptide and a nucleic acid that facilitate the detection and diagnosis of HDV infections, along with monitoring treatment efficacy. The patent also details an in vitro method and a diagnostic kit for point-of-care testing.

Career Highlights

Stephan Urban has worked with esteemed institutions, including Ruprecht-Karls-Universität Heidelberg. His research and innovations have significantly impacted the medical field, particularly in the areas of virology and metabolic diseases. Urban's dedication to advancing medical science is evident through his extensive patent portfolio.

Collaborations

Throughout his career, Urban has collaborated with notable professionals, including Walter Mier and Volker Cleeves. These partnerships have contributed to the success of his research and the development of his innovative patents.

Conclusion

Stephan Urban's contributions to medical science through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in the diagnosis and treatment of critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…